Company Overview
- Headquarters
- 280 Utah Ave Ste 250, South San Francisco CA
- Website
- siteonetherapeutics.com
- Phone
- (406) 602-4558
- Employees
- 1
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 54171 CompaniesNAICS Code 54 CompaniesNAICS Code 541 CompaniesNAICS Code 5417 CompaniesNAICS Code 541714 Companies
- SIC Code
-
SIC Code 87 CompaniesSIC Code 873 Companies
Financials & Stats
Revenue
$13B
Total Funding Amount
$17M
SiteOne Therapeutics Inc Industry Tags
Biotechnology Research
Companies Similar to SiteOne Therapeutics Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to SiteOne Therapeutics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
13M | 7 | Cleveland, OH | 2007 | |
12M | 10 | Woburn, MA | 2007 | |
12M | 21 | Cambridge, MA | ||
12M | 7 | Albuquerque, NM | 1990 | |
12M | 54 | Rochester, MN | 2012 |
FAQ
What is the location of SiteOne Therapeutics Inc's headquarters?
The headquarters of SiteOne Therapeutics Inc are situated at 280 Utah Ave Ste 250, South San Francisco CA
What is SiteOne Therapeutics Inc's phone number?
SiteOne Therapeutics Inc's contact number is (406) 602-4558.
What is SiteOne Therapeutics Inc's official website?
The official website of SiteOne Therapeutics Inc can be found at siteonetherapeutics.com.
What is SiteOne Therapeutics Inc's current revenue?
As of June 2022, SiteOne Therapeutics Inc's annual revenue reached $13B.
How many employees does SiteOne Therapeutics Inc currently have?
SiteOne Therapeutics Inc employs 1 person as of June 2022
Which industries is SiteOne Therapeutics Inc primarily operating in?
SiteOne Therapeutics Inc operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
What are SiteOne Therapeutics Inc's industry tags?
SiteOne Therapeutics Inc's industry tags include: Biotechnology Research
What is SiteOne Therapeutics Inc's total funding to date?
SiteOne Therapeutics Inc has secured $17M as of June 2022